Helen Lunde

454 total citations
11 papers, 323 citations indexed

About

Helen Lunde is a scholar working on Genetics, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Helen Lunde has authored 11 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Physiology. Recurrent topics in Helen Lunde's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Asthma and respiratory diseases (3 papers) and Vitamin K Research Studies (2 papers). Helen Lunde is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Asthma and respiratory diseases (3 papers) and Vitamin K Research Studies (2 papers). Helen Lunde collaborates with scholars based in Sweden, United Kingdom and Japan. Helen Lunde's co-authors include Thomas Hedner, Ola Samuelsson, Jan Lötvall, N Svedmyr, Lars Lindholm, B.‐E. Wiholm, Lennart Andrén, A. Ullman, Dag Elmfeldt and Hans Törnqvist and has published in prestigious journals such as Allergy, Journal of Hypertension and Survey of Ophthalmology.

In The Last Decade

Helen Lunde

11 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen Lunde Sweden	7	111	91	88	74	43	11	323
Philippe L. Selvais Belgium	12	141 1.3×	99 1.1×	39 0.4×	21 0.3×	39 0.9×	22	379
F Morich Germany	9	124 1.1×	61 0.7×	46 0.5×	59 0.8×	37 0.9×	20	373
Catherine Chollet France	11	76 0.7×	61 0.7×	69 0.8×	105 1.4×	9 0.2×	14	357
Helga Frank Germany	10	108 1.0×	53 0.6×	79 0.9×	9 0.1×	16 0.4×	17	297
Kaoru Yoshinaga Japan	9	121 1.1×	37 0.4×	65 0.7×	10 0.1×	42 1.0×	30	353
Jiro Toyonaga Japan	8	45 0.4×	28 0.3×	54 0.6×	14 0.2×	34 0.8×	14	383
Hideki KOH Japan	7	68 0.6×	275 3.0×	29 0.3×	14 0.2×	183 4.3×	17	498
Shinsaku Matsumoto Japan	11	133 1.2×	36 0.4×	49 0.6×	17 0.2×	8 0.2×	29	332
Lisa Sparks Australia	8	58 0.5×	147 1.6×	164 1.9×	101 1.4×	16 0.4×	13	478
A Blackwood United Kingdom	9	233 2.1×	20 0.2×	40 0.5×	29 0.4×	23 0.5×	10	337

Countries citing papers authored by Helen Lunde

Since Specialization

Citations

This map shows the geographic impact of Helen Lunde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Lunde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Lunde more than expected).

Fields of papers citing papers by Helen Lunde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Lunde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Lunde. The network helps show where Helen Lunde may publish in the future.

Co-authorship network of co-authors of Helen Lunde

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Lunde. A scholar is included among the top collaborators of Helen Lunde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Lunde. Helen Lunde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Johansson, Susanne, Boël Löfberg, Helen Lunde, et al.. (2016). In Silico Predictions and In Vivo Results of Drug–Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate. Clinical Pharmacology in Drug Development. 5(5). 364–373. 4 indexed citations

Belcher, G, et al.. (2000). THE COMBINATION TABLET OF CANDESARTAN CILEXETIL. Journal of Hypertension. 18. S94–S94. 5 indexed citations

Lunde, Helen, et al.. (1998). Efficacy of cumulative doses of salbutamol administered via Turbuhaler® or Diskhaler® in patients with reversible airway obstruction. Allergy. 53(7). 712–715. 5 indexed citations

Lötvall, Jan, Helen Lunde, & N Svedmyr. (1998). Onset of Bronchodilation and Finger Tremor Induced by Salmeterol and Salbutamol in Asthmatic Patients. Canadian Respiratory Journal. 5(3). 191–194. 18 indexed citations

Hedner, Jan, N Svedmyr, Helen Lunde, & Agneta Mandahl. (1997). The lack of respiratory effects of the ocular hypotensive drug latanoprost in patients with moderate-steroid treated asthma. Survey of Ophthalmology. 41. S111–S115. 23 indexed citations

Belcher, G, Richard Hubner, Mark S. George, Dag Elmfeldt, & Helen Lunde. (1997). Candesartan cilexetil: safety and tolerability in healthy volunteers and patients with hypertension.. PubMed. 11 Suppl 2. S85–9. 41 indexed citations

Lunde, Helen, et al.. (1994). Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ. 308(6920). 18–18. 50 indexed citations

Lötvall, Jan, et al.. (1994). Airway effects of direct left-sided cervical vagal stimulation in patients with complex partial seizures. Epilepsy Research. 18(2). 149–154. 20 indexed citations

Lötvall, Jan, Helen Lunde, A. Ullman, Hans Törnqvist, & N Svedmyr. (1992). Twelve months, treatment with inhaled salmeterol in asthmatic patients. Allergy. 47(5). 477–483. 47 indexed citations

10.

Hedner, Thomas, Ola Samuelsson, Helen Lunde, et al.. (1992). Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.. BMJ. 304(6832). 941–946. 104 indexed citations

11.

Hedner, Thomas, Ola Samuelsson, & Helen Lunde. (1992). Adrenaline in allergic emergencies: Authors' reply. BMJ. 304(6839). 1443–1443. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact